Previous Article | Next Article ![]()
Journal of Clinical Microbiology, October 1999, p. 3423-3424, Vol. 37, No. 10
Service de Parasitologie-Mycologie,
Received 27 January 1999/Returned for modification 26 April
1999/Accepted 24 June 1999
The serological diagnosis of toxoplasmic infection during pregnancy
is intended to prevent congenital infection of the fetus. However, in
the context of recurrent pregnancy loss intravenous immunoglobulin
therapy can create a biological trap for the interpretation of
serological results, with potentially serious consequences for the
outcome of the pregnancy.
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Intravenous Immunoglobulin Therapy: Confounding
Effects on Serological Screening for Toxoplasmosis during
Pregnancy
*
Corresponding author. Mailing address: Service de
Parasitologie-Mycologie, CHU A Michallon, BP 217, 38043 Grenoble Cedex, France. Phone: 33 4 76 76 54 90. Fax: 33 4 76 76 56 60. E-mail: Herve.Pelloux{at}ujf-grenoble.fr.
Journal of Clinical Microbiology, October 1999, p. 3423-3424, Vol. 37, No. 10
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»